Skip to content

The Center for Children Childhood Cancer Research
Menu Search
  • Laboratories & Research Programs
  • Research Topics
  • Our Team

CCCR Utility Menu

  • About the CCCR
  • Training
  • CCCR News
  • Donate
  • Locations
  • About the CCCR
  • Training
  • CCCR News
  • Donate
  • Locations
  • Laboratories & Research Programs
  • Research Topics
  • Our Team

Center for Childhood Cancer Research

The Center for Childhood Cancer Research represents a highly integrated basic, translational and clinical research environment dedicated to eradicating the pain and suffering caused by cancer in children.

Learn more about the CCCR

 

Scientist in lab

Laboratories & Research Programs

Our laboratories and research programs are uncovering the causes of childhood cancer and developing treatments that have improved the cure rates for these diseases.

test tube tray

Research Topics

The work of our investigators touches every type of childhood cancer. Through our research, we're finding ways to improve quality of life for cancer survivors.

Two scientists working in lab

Meet Our Team

Our physician-scientists are recognized world-wide for their significant contributions to the field of pediatric cancer research and for their compassionate care of children with cancer.

 

View more

FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia

This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this new era of cellular therapies that treat cancer with a patient’s own immune system.

T-cell Therapy Pioneered at CHOP Shows Persistent Benefits in Young Leukemia Patients

Updated results from a global clinical trial of the CAR T-cell therapy for ALL reveal that children and young adults continued to show high rates of durable, complete remission of their disease.

CHOP Researchers Identify Potential Target in Treating High-risk Childhood Cancers

Oncology researchers studying high-risk children’s cancers have identified a cell surface protein that may offer an important target for immunotherapy, a treatment that has the potential to zero in on cancer cells without harming healthy cells.

Footer Navigation

34th St and Civic Center Blvd
Philadelphia, PA 19104

  • Laboratories
  • Research Topics
  • Our Team
  • About CCCR
  • Donate
  • CCCR News
  • Training
  • ©2022 Children’s Hospital of Philadelphia
  • Terms of Use
  • Privacy Policy
  • Ethics & Compliance
  • Questions and Feedback